Drug therapy for the patient with resistant hypertension
- PMID: 25760878
- DOI: 10.2217/fca.15.9
Drug therapy for the patient with resistant hypertension
Abstract
Resistant hypertension is associated with high morbidity and mortality. Resistant hypertension is defined as blood pressure above targets despite treatment with at least three antihypertensive drugs in adequate dose and combination. Nonadherence is a frequent cause of uncontrolled hypertension and can be improved by providing fixed dose (of two or three agents) single pill combination. Triple combination of the most widely used antihypertensive agents (renin-angiotensin-aldosterone system antagonists, calcium channel blockers and diuretics) is a safe and effective therapy. Fourth line therapy is the use of an aldosterone antagonist. Renal denervation and baroreceptor stimulation can be considered in patients who remained uncontrolled despite optimal medical therapy.
Keywords: baroceptor stimulation; drug adherence; medical therapy; renal denervation; resistant hypertension.
Similar articles
-
Salt, the renin-angiotensin-aldosterone system and resistant hypertension.Hypertens Res. 2013 Aug;36(8):657-60. doi: 10.1038/hr.2013.69. Hypertens Res. 2013. PMID: 23912973 Review.
-
Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.Hypertension. 2011 Dec;58(6):1008-13. doi: 10.1161/HYPERTENSIONAHA.111.180497. Epub 2011 Oct 31. Hypertension. 2011. PMID: 22042809
-
[Pharmacological hypertension therapy].Ugeskr Laeger. 2009 Jun 8;171(24):2022-5. Ugeskr Laeger. 2009. PMID: 19523367 Danish.
-
Combination therapy in hypertension.Adv Ther. 2013 Apr;30(4):320-36. doi: 10.1007/s12325-013-0020-9. Epub 2013 Apr 3. Adv Ther. 2013. PMID: 23553510 Review.
-
Resistant Hypertension: Which Agent?Heart Lung Circ. 2018 Aug;27(8):911-916. doi: 10.1016/j.hlc.2018.02.013. Epub 2018 Mar 1. Heart Lung Circ. 2018. PMID: 29526418 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical